FAAH, fatty acid amide hydrolase, 2166

N. diseases: 177; N. variants: 8
Disease: Obesity, Morbid ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0028756
Disease: Obesity, Morbid
Obesity, Morbid 		0.040 GeneticVariation disease BEFREE Our findings provide evidence for an endocannabinoid-related phenotype that may be identified by the combination of circulating anandamide levels with genotyping of the FAAH 385C>A; this phenotype is not exclusive to mono-ethnoracial populations nor to individuals with severe obesity. 26561012 2015
CUI: C0028756
Disease: Obesity, Morbid
Obesity, Morbid 		0.040 Biomarker disease BEFREE The main research question here was whether quantitative measurement of plasma endocannabinoids, anandamide, and related N-acylethanolamines (NAEs), combined with genotyping for mutations in fatty acid amide hydrolase (FAAH) would identify circulating biomarkers of ECS activation in severe obesity. 20098695 2010
CUI: C0028756
Disease: Obesity, Morbid
Obesity, Morbid 		0.040 GeneticVariation disease BEFREE The fatty acid amide hydrolase (FAAH) Pro129Thr polymorphism is not associated with severe obesity in Greek subjects. 18819056 2008
CUI: C0028756
Disease: Obesity, Morbid
Obesity, Morbid 		0.040 GeneticVariation disease BEFREE Evaluating the association of FAAH common gene variation with childhood, adult severe obesity and type 2 diabetes in the French population. 20054193 2008